Market
BSE Prices delayed by 5 minutes... << Prices as on Aug 28, 2026 >>  ABB India  7505 [ 0.13% ] ACC  1306.8 [ -0.23% ] Ambuja Cements  413.05 [ -0.76% ] Asian Paints  2602 [ -1.06% ] Axis Bank  1264 [ 1.12% ] Bajaj Auto  11920 [ 2.10% ] Bank of Baroda  241.5 [ 2.09% ] Bharti Airtel  1882 [ 0.21% ] Bharat Heavy  430.5 [ -0.58% ] Bharat Petroleum  318.05 [ -0.55% ] Britannia Industries  5310.6 [ 0.27% ] Cipla  1418 [ -0.13% ] Coal India  401 [ -0.25% ] Colgate Palm  1830.7 [ -0.73% ] Dabur India  385 [ -0.35% ] DLF  676.35 [ 0.20% ] Dr. Reddy's Lab.  1177.8 [ 0.24% ] GAIL (India)  171 [ -1.30% ] Grasim Industries  3289 [ 0.74% ] HCL Technologies  1316.5 [ 2.68% ] HDFC Bank  720 [ 1.12% ] Hero MotoCorp  5604.75 [ 1.18% ] Hindustan Unilever  2010.4 [ 0.17% ] Hindalco Industries  1036.95 [ 1.26% ] ICICI Bank  1425.2 [ -1.30% ] Indian Hotels Co.  705.4 [ -2.03% ] IndusInd Bank  992.9 [ 2.36% ] Infosys  1143.65 [ 3.34% ] ITC  266 [ -0.52% ] Jindal Steel  1177 [ 0.87% ] Kotak Mahindra Bank  423.75 [ 0.11% ] L&T  4041 [ 0.20% ] Lupin  2175 [ 0.48% ] Mahi. & Mahi  3332.4 [ -0.17% ] Maruti Suzuki India  13385.5 [ -0.32% ] MTNL  27.37 [ 3.09% ] Nestle India  1455.75 [ 0.43% ] NIIT  105.43 [ 2.40% ] NMDC  86.65 [ 0.76% ] NTPC  331.5 [ 0.85% ] ONGC  232.2 [ 0.09% ] Punj. NationlBak  115.4 [ 3.04% ] Power Grid Corpn.  266.95 [ 0.79% ] Reliance Industries  1284.4 [ -0.12% ] SBI  1046.05 [ 0.11% ] Vedanta  287.1 [ 2.17% ] Shipping Corpn.  298.85 [ 2.15% ] Sun Pharmaceutical  1920.1 [ 1.03% ] Tata Chemicals  656.55 [ 1.93% ] Tata Consumer  1040.5 [ -0.13% ] Tata Motors Passenge  319 [ 0.90% ] Tata Steel  186.2 [ -0.11% ] Tata Power Co.  351.65 [ -0.10% ] Tata Consult. Serv.  2344 [ 4.09% ] Tech Mahindra  1636 [ 3.18% ] UltraTech Cement  11579.5 [ -1.18% ] United Spirits  1500 [ -1.43% ] Wipro  180.4 [ 1.92% ] Zee Entertainment  101.55 [ -2.40% ] 
Glenmark Pharmaceuticals Ltd. Auditor Report
Search Company 
You can view full text of the latest Auditor's Report for the company.
Market Cap. (Rs.) 70979.51 Cr. P/BV 6.46 Book Value (Rs.) 389.58
52 Week High/Low (Rs.) 2538/1793 FV/ML 1/1 P/E(X) 52.12
Bookclosure 31/08/2026 EPS (Rs.) 48.25 Div Yield (%) 0.20
Year End :2026-03 

1. We have audited the accompanying standalone financial
statements of
Glenmark Pharmaceuticals Limited

('the Company'), which comprise the Standalone Balance
Sheet as at
31 March 2026, the Standalone Statement
of Profit and Loss (including Other Comprehensive
Income), the Standalone Statement of Cash Flow and
the Standalone Statement of Changes in Equity for the
year then ended, and notes to the standalone financial
statements, including material accounting policy
information and other explanatory information.

2. In our opinion and to the best of our information and
according to the explanations given to us, the aforesaid
standalone financial statements give the information
required by the Companies Act, 2013 ('the Act') in the
manner so required and give a true and fair view in
conformity with the Indian Accounting Standards
('Ind AS') specified under section 133 of the Act read
with the Companies (Indian Accounting Standards)
Rules, 2015 and other accounting principles generally
accepted in India, of the state of affairs of the Company
as at 31 March 2026, and its profit (including other
comprehensive income), its cash flows and the changes
in equity for the year ended on that date.

Basis for Opinion

3. We conducted our audit in accordance with the
Standards on Auditing specified under section 143(10)
of the Act. Our responsibilities under those standards
are further described in the Auditor's Responsibilities for
the Audit of the Standalone Financial Statements section
of our report. We are independent of the Company in
accordance with the Code of Ethics issued by the Institute
of Chartered Accountants of India ('ICAI') together with
the ethical requirements that are relevant to our audit of
the standalone financial statements under the provisions
of the Act and the rules thereunder, and we have fulfilled
our other ethical responsibilities in accordance with
these requirements and the Code of Ethics. We believe
that the audit evidence we have obtained is sufficient
and appropriate to provide a basis for our opinion.

Key Audit Matters

4. Key audit matters are those matters that, in our
professional judgment, were of most significance in
our audit of the standalone financial statements of
the current period. These matters were addressed
in the context of our audit of the standalone financial
statements as a whole, and in forming our opinion
thereon, and we do not provide a separate opinion on
these matters.

5. We have determined the matters described below to be the key audit matters to be communicated in our report.

Key audit matters

How our audit addressed the key audit matters

Litigations and claims - provisions and contingent

Our audit procedures, related to provisions and contingent

liabilities

liabilities, included, but were not limited, to the following:

Refer note 2.16 to the accompanying standalone financial

• Obtained an understanding from the management with

statements for the related accounting policy on Provisions,

respect to process and controls followed by the Company

contingent liabilities and contingent assets and note 30(i) for

for:

contingent liabilities disclosures.

- identification and monitoring of significant

The Company is involved in various legal proceedings

developments in relation to the litigations,

including product liability, contracts, employment claims,

including completeness thereof;

and other regulatory matters relating to the conduct of its

- assessment of accounting treatment for each such

business.

litigation identified under Ind AS 37 accounting

The amounts involved are material and the application of

principles; and

accounting principles as given under Ind AS 37, Provisions,

- measurement of amounts involved.

Contingent Liabilities and Contingent Assets, in order to

• Evaluated the design and tested the operating

determine the amount to be recorded as a liability or to be
disclosed as a contingent liability.

effectiveness of key controls around above process;

• Obtained the list of litigations from the management

The eventual outcome of the litigations in each case is

and reviewed their assessment of the likelihood of

uncertain and estimation at balance sheet date involves

outflow of economic resources being probable, possible

extensive judgement of management including input from

or remote in respect of the litigations. This involved

legal counsel due to complexity of each litigation. Adverse

assessing the probability of an unfavorable outcome

outcomes could significantly impact on the Company's

of a given proceeding and the reliability of estimates of

reported results and balance sheet position.

related amounts;

Key audit matters

How our audit addressed the key audit matters

Considering the judgement involved in determining the need

Circulated, obtained, and read legal confirmations from

to make a provision or disclose as contingent liability, the

Company's external legal counsels in respect of material

matter is considered a key audit matter.

litigation and considered that in our assessment.

Verified the disclosures related to provisions and contingent
liabilities in the standalone Ind AS financial statements to
assess consistency with underlying documents.

Revenue from operations

Our audit included, but was not limited to, the following

Refer note 2.4 to the accompanying standalone financial

procedures:

statements for the related accounting policy on revenue

a)

Obtained an understanding of the management's

recognition and note 18 for details of revenue recognised

process for revenue recognition, judgments in estimation

during the year.

and accounting treatment of discount schemes, returns,

The Company recognizes revenue from sales of pharmaceutical

rebates and other price adjustments;

products, when control of the product is transferred. The

b)

Evaluated the design and tested the operating

Company records product sales net of estimated discounts,

effectiveness of the key controls, including general

right to returns, rebates and other price adjustments. The

IT controls, key IT application controls exercised by

actual point in time when revenue is recognized varies

the management, over recognition of revenue and

depending on the specific terms and conditions of the sales

measurement of various discount, right to returns,

contracts entered with customers.

rebates and other price adjustments;

Further, the Company has a large number of customers

c)

Performed substantive testing by selecting samples

operating in various geographies and sales contracts with

of revenue transactions pertaining to sale of products

customers have different terms relating to the recognition

during the year and verified the underlying supporting

of revenue leading to material deductions from gross sales

documents including contracts, agreements, sales

which includes discounts, right to return, rebates and other

invoices and dispatch/ shipping documents;

price adjustments in accordance with principles of Ind AS 115,
"Revenue from Contracts with Customers" ('Ind AS 115').

d)

Performed substantive testing by selecting samples
of revenue transactions pertaining to sale of products

We identified the recognition of revenue from operations as a
key audit matter because:

during specific periods before and after year end to
ensure that the correct amount of revenue is recorded in
the correct period;

• Accrual towards discounts, right to returns, and other

price adjustments is complex and requires significant

e)

Obtained management workings for amounts

judgments and estimates in relation to contractual

recognized towards discount schemes, right to returns

agreements/ commercial terms across various

and rebates and other price adjustments during the

geographies. Any change in these estimates can have a

year and as at year end. On a sample basis, tested the

significant financial impact.

underlying calculations for amounts recorded as accruals
and provisions towards the aforementioned obligations,

• The Company considers revenue as key benchmark for

as per the terms of related schemes, contracts and

evaluating performances and hence, there is risk of

regulations and traced the underlying data to source

revenue being overstated due to pressure to achieve
targets, earning expectations or incentive schemes

documents;

linked to performance for a reporting period.

f)

Evaluated historical accuracy of the Company's
estimates of year-end accruals pertaining to aforesaid
arrangements made in the previous years to identify any
management bias;

g)

Tested the manual sales-related adjustments made to
revenue comprising of variable consideration under
Ind AS 115 to ensure the appropriateness of revenue
recognition during the year; and

h)

Evaluated the appropriateness and adequacy of
disclosures given in the standalone financial statements
in accordance with applicable accounting standards.

Based on audit procedures performed, we determined that

the

revenue recognition and measurement is appropriate

in the context of the standalone financial statements taken
as a whole.

Key audit matters

How our audit addressed the key audit matters

Impairment of investments in and loss allowances of loans

Our audit included, but was not limited to, the following

given to subsidiaries [Refer note 5(i)(A)(a) and 5(ii) of the

procedures:

standalone financial statements]

• Assessed the appropriateness of accounting policy in

As at 31 March 2026, the Company has investments in

respect of impairment and loss allowances in accordance

subsidiaries of ' 151,598.55 million (net of provision for

with Ind AS.

impairment) and has loans to subsidiaries of ' 55,820.74
million.

• Obtained understanding of management's process
for loss allowances and for identification of indicators

Investments in subsidiaries are accounted for at cost less

of impairment. Evaluated the design and tested the

impairment loss, if any. Loans given to subsidiaries are

operating effectiveness of internal controls over loss

measured at amortised cost.

allowances and impairment assessment process.

Loans are assessed for loss allowances and investments are

• Obtained management assessment on impairment

assessed for impairment annually or earlier if indicator exists.

indicators and tested the mathematical accuracy of the

If indicators exist, the loss allowances of loans and impairment
of the investments are estimated in order to determine the
extent of loss allowances and impairment losses, if any. Any

underlying calculations and traced such information
to source financial information relating to subsidiary
company;

such losses are recognised in Statement of Profit and Loss.

• Obtained impairment assessment working from the

Management judgement is required in assessing impairment
indicators and recoverable amount for impairment testing.

management and tested the arithmetical accuracy of
valuation model.

The recoverable amounts have been determined by the

• Evaluated and challenged management's assumptions

management using discounted cash flow valuation method.

used in the impairment assessment, particularly those

Key assumptions underpinning management's assessment
of the recoverable amounts include but are not limited to
projection of future cash flows, revenue growth rates,
terminal values, operating profit margins, estimated future

related to cash flow projections, discount rates,
growth rates, etc. considering approved business
plans, tariff orders, evidence available to support these
and our understanding of the business.

operating capital expenditure, external market conditions

• Performed independent sensitivity analysis for

and discount rates.

reasonably possible changes in the key assumptions

Changes to these assumptions could lead to material
changes in estimated recoverable amounts, resulting in either
impairment or reversals of impairment taken in prior years.

used to evaluate the possible variation on the current
recoverable amount to ascertain the sufficiency of
headroom available; and

We determined impairment of investments and loss
allowances of loans given to subsidiaries as a key audit matter
since these assessments are complex and involve significant
management estimation and judgement.

• Evaluated the appropriateness and adequacy of
disclosures given in the accompanying standalone
financial statements in accordance with applicable
accounting standards.

Information other than the Standalone
Financial Statements and Auditor's Report
thereon

6. The Company's Board of Directors are responsible for
the other information. The other information comprises
the information included in the Annual Report but does
not include the standalone financial statements and our
auditor's report thereon.

Our opinion on the standalone financial statements does
not cover the other information and we do not express
any form of assurance conclusion thereon.

In connection with our audit of the standalone financial
statements, our responsibility is to read the other
information and, in doing so, consider whether the other
information is materially inconsistent with the standalone
financial statements or our knowledge obtained in the
audit or otherwise appears to be materially misstated.
If, based on the work we have performed, we conclude
that there is a material misstatement of this other

information, we are required to report that fact. We have
nothing to report in this regard.

Responsibilities of Management and Those
Charged with Governance for the Standalone
Financial Statements

7. The accompanying standalone financial statements have
been approved by the Company's Board of Directors.
The Company's Board of Directors are responsible
for the matters stated in section 134(5) of the Act with
respect to the preparation and presentation of these
standalone financial statements that give a true and
fair view of the financial position, financial performance
including other comprehensive income, changes in
equity and cash flows of the Company in accordance
with the Ind AS specified under section 133 of the Act
and other accounting principles generally accepted in
India. This responsibility also includes maintenance of
adequate accounting records in accordance with the
provisions of the Act for safeguarding of the assets of

the Company and for preventing and detecting frauds
and other irregularities; selection and application of
appropriate accounting policies; making judgments and
estimates that are reasonable and prudent; and design,
implementation and maintenance of adequate internal
financial controls, that were operating effectively
for ensuring the accuracy and completeness of the
accounting records, relevant to the preparation and
presentation of the financial statements that give a true
and fair view and are free from material misstatement,
whether due to fraud or error.

8. In preparing the standalone financial statements, the
Board of Directors is responsible for assessing the
Company's ability to continue as a going concern,
disclosing, as applicable, matters related to going
concern and using the going concern basis of accounting
unless the Board of Directors either intends to liquidate
the Company or to cease operations, or has no realistic
alternative but to do so.

9. The Board of Directors is also responsible for overseeing
the Company's financial reporting process.

Auditor's Responsibilities for the Audit of the
Standalone Financial Statements

10. Our objectives are to obtain reasonable assurance about
whether the standalone financial statements as a whole
are free from material misstatement, whether due
to fraud or error, and to issue an auditor's report that
includes our opinion. Reasonable assurance is a high
level of assurance, but is not a guarantee that an audit
conducted in accordance with Standards on Auditing will
always detect a material misstatement when it exists.
Misstatements can arise from fraud or error and are
considered material if, individually or in the aggregate,
they could reasonably be expected to influence the
economic decisions of users taken on the basis of these
standalone financial statements.

11. As part of an audit in accordance with Standards on
Auditing, specified under section 143(10) of the Act
we exercise professional judgment and maintain
professional skepticism throughout the audit. We also:

• Identify and assess the risks of material
misstatement of the standalone financial
statements, whether due to fraud or error, design
and perform audit procedures responsive to those
risks, and obtain audit evidence that is sufficient
and appropriate to provide a basis for our opinion.
The risk of not detecting a material misstatement
resulting from fraud is higher than for one resulting
from error, as fraud may involve collusion, forgery,
intentional omissions, misrepresentations, or the
override of internal control;

• Obtain an understanding of internal control relevant
to the audit in order to design audit procedures
that are appropriate in the circumstances. Under

section 143(3)(i) of the Act we are also responsible
for expressing our opinion on whether the
Company has adequate internal financial controls
with reference to financial statements in place and
the operating effectiveness of such controls;

• Evaluate the appropriateness of accounting
policies used and the reasonableness of accounting
estimates and related disclosures made by
management;

• Conclude on the appropriateness of Board of
Directors' use of the going concern basis of
accounting and, based on the audit evidence
obtained, whether a material uncertainty exists
related to events or conditions that may cast
significant doubt on the Company's ability to
continue as a going concern. If we conclude that
a material uncertainty exists, we are required to
draw attention in our auditor's report to the related
disclosures in the standalone financial statements
or, if such disclosures are inadequate, to modify our
opinion. Our conclusions are based on the audit
evidence obtained up to the date of our auditor's
report. However, future events or conditions may
cause the Company to cease to continue as a going
concern; and

• Evaluate the overall presentation, structure and
content of the standalone financial statements,
including the disclosures, and whether the
standalone financial statements represent the
underlying transactions and events in a manner
that achieves fair presentation.

12. We communicate with those charged with governance
regarding, among other matters, the planned scope
and timing of the audit and significant audit findings,
including any significant deficiencies in internal control
that we identify during our audit.

13. We also provide those charged with governance with
a statement that we have complied with relevant
ethical requirements regarding independence, and to
communicate with them all relationships and other
matters that may reasonably be thought to bear on
our independence, and where applicable, related
safeguards.

14. From the matters communicated with those charged
with governance, we determine those matters that
were of most significance in the audit of the standalone
financial statements of the current period and are
therefore the key audit matters. We describe these
matters in our auditor's report unless law or regulation
precludes public disclosure about the matter or when,
in extremely rare circumstances, we determine that
a matter should not be communicated in our report
because the adverse consequences of doing so would
reasonably be expected to outweigh the public interest
benefits of such communication.

Other Matter

15. The standalone financial statements of the Company
for the year ended 31 March 2025 were audited by
the predecessor auditor, Suresh Surana & Associates
LLP, Chartered Accountants who have expressed an
unmodified opinion on those standalone financial
statements vide their audit report dated 23 May 2025.

Report on Other Legal and Regulatory
Requirements

16. As required by section 197(16) of the Act, based on our
audit, we report that the Company has paid remuneration
to its directors during the year in accordance with the
provisions of and limits laid down under section 197 read
with Schedule V to the Act.

17. As required by the Companies (Auditor's Report) Order,
2020 ('the Order') issued by the Central Government of
India in terms of section 143(11) of the Act we give in
the Annexure A a statement on the matters specified in
paragraphs 3 and 4 of the Order, to the extent applicable.

18. Further to our comments in Annexure A, as required by
section 143(3) of the Act based on our audit, we report,
to the extent applicable, that:

a) We have sought and obtained all the information
and explanations which to the best of our knowledge
and belief were necessary for the purpose of our
audit of the accompanying standalone financial
statements;

b) Except for the matters stated in paragraph 18(h)
(vi) below on reporting under Rule 11(g) of the
Companies (Audit and Auditors) Rules, 2014 (as
amended), in our opinion, proper books of account
as required by law have been kept by the Company
so far as it appears from our examination of those
books;

c) The standalone financial statements dealt with
by this report are in agreement with the books of
account;

d) In our opinion, the aforesaid standalone financial
statements comply with Ind AS specified under
section 133 of the Act;

e) On the basis of the written representations
received from the directors and taken on record
by the Board of Directors, none of the directors
is disqualified as on 31 March 2026 from being
appointed as a director in terms of section 164(2)
of the Act;

f) The modification relating to the maintenance of
accounts and other matters connected therewith are
as stated in paragraph 18(b) above on reporting under
section 143(3)(b) of the Act and paragraph 18(h)(vi)
below on reporting under Rule 11(g) of the Companies
(Audit and Auditors) Rules, 2014 (as amended);

g) With respect to the adequacy of the internal
financial controls with reference to financial
statements of the Company as on 31 March 2026
and the operating effectiveness of such controls,
refer to our separate report in Annexure B wherein
we have expressed an unmodified opinion; and

h) With respect to the other matters to be included
in the Auditor's Report in accordance with rule 11
of the Companies (Audit and Auditors) Rules, 2014
(as amended), in our opinion and to the best of
our information and according to the explanations
given to us:

i. The Company, as detailed in note 13(iv), Note
16 and Note 30(i) to the standalone financial
statements, has disclosed the impact of
pending litigations on its financial position as
at 31 March 2026;

ii. The Company did not have any long-term
contracts including derivative contracts for
which there were any material foreseeable
losses as at 31 March 2026;

iii. There has been no delay in transferring
amounts, required to be transferred, to the
Investor Education and Protection Fund by
the Company during the year ended 31 March
2026;

iv. a. The management has represented

that, to the best of its knowledge and
belief, as disclosed in note 41(c) to the
standalone financial statements, no
funds have been advanced or loaned or
invested (either from borrowed funds or
securities premium or any other sources
or kind of funds) by the Company to or
in any person(s) or entity(ies), including
foreign entities ('the intermediaries'),
with the understanding, whether
recorded in writing or otherwise, that the
intermediary shall, whether, directly or
indirectly lend or invest in other persons
or entities identified in any manner
whatsoever by or on behalf of the
Company ('the Ultimate Beneficiaries')
or provide any guarantee, security or the
like on behalf the Ultimate Beneficiaries;

b. The management has represented that,
to the best of its knowledge and belief, as
disclosed in note 41(i) to the standalone
financial statements, no funds have
been received by the Company from any
person(s) or entity(ies), including foreign
entities ('the Funding Parties'), with the
understanding, whether recorded in
writing or otherwise, that the Company
shall, whether directly or indirectly, lend
or invest in other persons or entities

identified in any manner whatsoever
by or on behalf of the Funding Party
('Ultimate Beneficiaries') or provide any
guarantee, security or the like on behalf
of the Ultimate Beneficiaries; and

c. Based on such audit procedures
performed as considered reasonable
and appropriate in the circumstances,
nothing has come to our notice that
has caused us to believe that the
management representations under
sub-clauses (a) and (b) above contain
any material misstatement.

v. a. The interim dividend declared and paid

by the Company during the year ended
31 March 2026 and until the date of
this audit report is in accordance with
section 123 of the Act.

b. The final dividend paid by the Company
during the year ended 31 March 2026
in respect of such dividend declared for
the previous year is in accordance with
section 123 of the Act to the extent it
applies to payment of dividend.

c. As stated in note 36 to the accompanying
standalone financial statements, the
Board of Directors of the Company have
proposed final dividend for the year
ended 31 March 2026 which is subject
to the approval of the members at the
ensuing Annual General Meeting. The
dividend declared is in accordance with
section 123 of the Act to the extent it
applies to declaration of dividend.

vi. As stated in Note 41(l) to the standalone
financial statements and based on our
examination which included test checks,

except for instances mentioned below,
the Company, in respect of financial year
commencing on or after 1 April 2025, has
used an accounting software for maintaining
its books of account which have a feature of
recording audit trail (edit log) facility and the
same have been operated throughout the
year for all relevant transactions recorded in
the software. Further, during the course of
our audit we did not come across any instance
of audit trail feature being tampered with
other than the consequential impact of the
exception given below. Furthermore, except
for instances mentioned below, the audit
trail has been preserved by the Company as
per the statutory requirements for record
retention.

Nature of exception noted

Details of Exception

Instances of accounting
software for maintaining
books of account for which
the feature of recording
audit trail (edit log)
facility was not operated
throughout the year for
all relevant transactions
recorded in the software.

The audit trail feature
was not enabled at
the database level for
accounting software to log
any direct data changes,
used for maintenance of all
accounting records by the
Company.

For Walker Chandiok & Co LLP

Chartered Accountants

Firm's Registration No.: 001076N/N500013

Ashish Gupta

Partner

Membership No.: 504662
UDIN: 26118782BGAZYG9314

Place: Mumbai
Date: 29 May 2026


 
KYC IS ONE TIME EXERCISE WHILE DEALING IN SECURITIES MARKETS - ONCE KYC IS DONE THROUGH A SEBI REGISTERED INTERMEDIARY (BROKER, DP, MUTUAL FUND ETC.), YOU NEED NOT UNDERGO THE SAME PROCESS AGAIN WHEN YOU APPROACH ANOTHER INTERMEDIARY. | PREVENT UNAUTHORISED TRANSACTIONS IN YOUR ACCOUNT --> UPDATE YOUR MOBILE NUMBERS/EMAIL IDS WITH YOUR STOCK BROKER/DEPOSITORY PARTICIPANT. RECEIVE INFORMATION/ALERT OF YOUR TRANSACTIONS DIRECTLY FROM EXCHANGE/NSDL ON YOUR MOBILE/EMAIL AT THE END OF THE DAY .......... ISSUED IN THE INTEREST OF INVESTORS
Disclaimer Clause | Privacy | Terms of Use | Rules and regulations | Feedback| IG Redressal Mechanism | Investor Charter | Client Bank Accounts
Stocks A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Others
MUTUAL FUND A B C D E F G H I J K L M N O P Q R S T U V W X Y Z OTHERS
Right and Obligation, RDD, Guidance Note in Vernacular Language
Attention Investors : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
  "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
  "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participants. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day.Issued in the interest of Investors."
Regd. Office: 76-77, Scindia House, 1st Floor, Janpath, Connaught Place, New Delhi – 110001
NSE CASH , NSE F&O,NSE CDS| BSE CASH ,BSE CDS |DP NSDL | MCX-SX SEBI NO: INZ000155732

Compliance Officer: Mukesh Rustagi, Company Secretary, Tel: 011-46890000, Email: mukesh_rustagi80@hotmail.com
For grievances please e-mail at: kkslig@hotmail.com

Important Links : NSE | BSE | MCX | SEBI | NSDL | Speed-e | CDSL | SCORES | NSDL E-voting | CDSL E-voting | SMART ODR | ODR CIRCULAR
 
Charts are powered by TradingView.
Copyrights @ 2014 © KK Securities Limited. All Right Reserved
Designed, developed and content provided by